BDBM703915 6-(2-fluorophenyl)-4-methyl-1,5-naphthyridin-2- amine. LCMS [M + 1] = 254.3. 1H NMR (400 MHz, MeOD) $#948; = 8.10 (dt, J = 1.8, 8.0 Hz, 1H), 7.97- 7.92 (m, 1H), 7.90-7.85 (m, 1H), 7.49-7.40 (m, 1H), 7.34-7.28 (t, J = 7.6, 1H), 7.26-7.19 (m, 1H), 6.95 (d, J = 1.2 Hz, 1H), 2.70 (d, J = 0.8 Hz, 3H).::US20240368153, Example 4-7
SMILES Cc1cc(N)nc2ccc(-c3ccccc3F)nc12
InChI Key
Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB
Found 5 hits for monomerid = 703915
TargetProtein arginine N-methyltransferase 5 (PRMT5) and Methylosome protein WDR77 (MEP-50)(Human)
Mirati Therapeutics
US Patent
Mirati Therapeutics
US Patent
TargetProtein arginine N-methyltransferase 5 (PRMT5) and Methylosome protein WDR77 (MEP-50)(Human)
Mirati Therapeutics
US Patent
Mirati Therapeutics
US Patent
TargetProtein arginine N-methyltransferase 5 (PRMT5) and Methylosome protein WDR77 (MEP-50)(Human)
Mirati Therapeutics
US Patent
Mirati Therapeutics
US Patent
TargetProtein arginine N-methyltransferase 5 (PRMT5) and Methylosome protein WDR77 (MEP-50)(Human)
Mirati Therapeutics
US Patent
Mirati Therapeutics
US Patent
TargetProtein arginine N-methyltransferase 5 (PRMT5) and Methylosome protein WDR77 (MEP-50)(Human)
Mirati Therapeutics
US Patent
Mirati Therapeutics
US Patent